Multi-omics profiling implicates gut microbiota-sphingolipid interplay in the neuroprotective effects of semaglutide on diabetic cognitive impairment. [PDF]
Qi L +10 more
europepmc +1 more source
Periconceptional GLP-1 receptor agonist exposure and obstetric outcomes: a Danish nationwide cohort study. [PDF]
Hviid KVR +7 more
europepmc +1 more source
Real-world 6-month persistence, adherence, and effectiveness of GLP-1 medications for overweight and obesity in a Medicaid population. [PDF]
Meyer KB +10 more
europepmc +1 more source
Topic and Sentiment Trends in Semaglutide Discussions on X: Subpopulation-Based Longitudinal Analysis. [PDF]
Momeni P +3 more
europepmc +1 more source
Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX-SEMA 2.4 mg, an Italian real-world study. [PDF]
Pampanelli S +12 more
europepmc +1 more source
Not All Weight Loss Is Equal: Towards Muscle‐Preserving Therapies in Obesity
Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 3, June 2026.
Joseph D. Abraham +2 more
wiley +1 more source
GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?
The Laryngoscope, Volume 136, Issue 6, Page 2406-2409, June 2026.
Alina Zgardau +3 more
wiley +1 more source

